mdxhealth.com - חוב לטווח קצר של החברה MDXH

The current market quotes visualized below allow for an assessment of the debt load of MDxHealth (MDXH), where the indicator stands at 0.00. MDxHealth (MDXH) is developing molecular detection methods for prostate tumors to reduce the number of unnecessary invasive procedures. However, the business faces pressure from industry behemoths that are undercutting prices through volume, and it continues to fight for the recognition of its tests by insurance companies.

This metric accumulates obligations with maturities of up to one year, determining the company's resilience to sudden liquidity shortages. For the investor, this figure serves as an indicator of the risk of a cash gap should operating revenue decline. At MDxHealth SA (MDXH), the burden may increase as the centralized laboratory network expands to scale diagnostics. Analyzing historical short-term debt data allows for the identification of hidden financial imbalances. A sharp spike in the curve signals potential for short positions.